Skip to main content

For the best listening experience and to never miss an episode, subscribe to The Decibel on your favourite podcast app or platform: Apple Podcasts, Spotify, Amazon Music, Stitcher, Google Podcasts, iHeartRadio, Pocket Casts and Youtube.


Ozempic and other semaglutide drugs have been hailed as a very effective treatment for obesity, but shortages, affordability and doctors’ willingness to prescribe it are still keeping people who might benefit from it off the drug.

Health reporter Carly Weeks explains how the drug works and how it may force our society to rethink how we perceive obesity.

Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com